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Abstract: The aim of this study is to examine the growth inhibitory effects of methanolic 
leaf and fruit extracts of L. vulgare on HCT-116 cells over different time periods and their 
synergistic effect with a Pd(apox) complex. The antiproliferative activity of plant extracts 
alone or in combination with the Pd(apox) complex was determined using MTT cell 
viability assay, where the IC50 value was used as a parameter of cytotoxicity. Results show 
that antiproliferative effects of L. vulgare extracts increase with extension of exposure time, 
with decreasing IC50 values, except for 72 h where the IC50 values for methanolic leaf 
extract were lower than for the fruit extract. The Pd(apox) complex alone had a weak 
antiproliferative effect, but combination with L. vulgare extracts caused stronger effects 
with lower IC50 values than with L. vulgare extracts alone. The type of cell death was 
explored by fluorescence microscopy using the acridin orange/ethidium bromide method. 
Treatments with plant extracts caused typical apoptotic morphological changes in   
HCT-116 cells and co-treatments with Pd(apox) complex caused higher levels of apoptotic 
cells than treatment with plant extracts alone. The results indicate that L. vulgare is a 
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considerable source of natural bioactive substances with antiproliferative activity on   
HCT-116 cells and which have a substantial synergistic effect with the Pd(apox) complex.  
Keywords: acridin orange/ethidium bromide assay; antiprolifertative activity; apoptosis; 
cotreatment; Ligustrum vulgare L.; MTT assay; palladium; time dependance  
 
1. Introduction 
Wild privet, Ligustrum vulgare L. (Oleaceae) is a semi-evergreen woody branched bush, growing to 
5 m tall. The stems are stiff, erect and with grey-brown spotted bark; leaves are lanceolate or broadly 
elliptical, 2–7 cm long and 0.5–2 cm broad. The flowers are white and fragrant, forming a pyramidal 
panicle. The fruit is a small glossy black berry of 6–8 mm diameter, containing one to four seeds. It 
usually inhabits forest ecosystems of Central and Southern Europe, North Africa and Southwest Asia, 
and is often cultivated as an ornamental plant [1].  
Leaves of L. vulgare are used for disease prevention or treatment in folk medicine in southern 
Europe [2], mostly because of their immunomodulatory [3], cardioprotective [4], antibacterial [5], 
antidiabetic effects [6], and it has also been found that different leaf and fruit extracts of this plant can 
scavenge OH and DPPH radicals [7]. From the traditional uses and later scientific findings, which 
suggested cytotoxic activity against HeLa cells [8], L. vulgare may be a potential candidate as an 
antiproliferative agent against cancer cell lines. Different in vitro assays performed in L. vulgare leaves 
show broad pharmacological potential of this plant due to the presence of flavonoids, 
phenylpropanoids and terpenoids (mainly secoiridoids) [2,9]. However, there is no data available on 
the antiproliferative activity of L. vulgare fruit extracts.  
Nature has long been an important source of medicinal agents. An impressive number of   
modern drugs have been isolated or derived from natural sources, based on their use in traditional 
medicine [10,11]. Ethnopharmacological or traditional use of plants often results in the discovery of 
new biologically active molecules [12]. A wide variety of secondary metabolites obtained from plants 
are tested for their ability to treat cancer. Various plant-derived anti-cancer drugs are known to be 
effective against proliferating cells. In addition, there are chemotherapeutic compounds commonly 
used to fight cancer, such as cisplatin [13]. Although cisplatin is a valuable antitumor drug, it has 
several disadvantages including side effects such as nephrotoxicity, ototoxicity, neurotoxicity, 
myelotoxicity, peripheral neuropathy and hematological toxicity [14]. The adverse effects observed in 
patients receiving cisplatin chemotherapy have generated new areas of research mainly focused on the 
search for new nonplatinum metal-based complexes displaying low toxicity with improved therapeutic 
properties. A new [Pd(apox)] complex was synthesized in an attempt to obtain compounds with 
superior chemotherapeutic index in terms of increased bioavailability, higher cytotoxicity, and lower 
side effects than cisplatin. The coordination chemistry of palladium(II) is very similar to that of 
platinum(II), but the higher lability in ligand exchange at the Pd centre (10
5-fold vs. Pt) may cause 
rapid hydrolysis processes leading to the dissociation of the complex and formation of very reactive 
species unable to reach their biological targets. This issue could be overcome by using bulky 
heterocyclic and chelating ligands. Here we used the chelating ligand H2apox(N,N'-bis(3-Int. J. Mol. Sci. 2012, 13                 
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aminopropyl)oxamido) to synthesize a neutral N,N'-bis(3-aminopropyl)oxamido palladium(II) complex. 
In the equatorial plane, the complex contains fully deprotonated bidentate ligands capable of forming a 
five-membered (oxamido) backbone. 
The aim of this study is to examine the growth inhibitory effects of methanolic leaf and fruit 
extracts of L. vulgare, on human colon cancer cells (HCT-116) over different time periods by two 
different assays along with their synergistic effect with Pd(apox) complex, as well as to examine the 
type of cell death. 
2. Results and Discussion 
2.1. Time- and Dose-Dependent Effects of L. vulgare Extracts on Cell Proliferation 
We conducted two in vitro experiments on human colon cancer cells—HCT-116 cell line. The MTT 
cell viability assay in vitro is the primary stage for screening. Cells were treated with different 
concentrations of plant extracts (in concentration range from 1 to 500 μg/mL) at different duration 
ranges (3, 6, 12, 24, 48 or 72 h) to clarify the role of the time of exposure. Figure 1 shows the dose and 
time-dependent activity of extracts for all duration ranges. We chose different incubation times to 
determine the most effective one. While the inhibition of cell viability was obtained after 3 h of 
treatment only for the highest concentrations, prolonged treatments (6, 12, 24 and 72 h) caused 
significant inhibition of viability for all concentrations. The anti-proliferative activity of the L. vulgare 
extracts depended on the exposure time. However, the cell proliferation at 72 h treatment resulted in an 
increase in IC50 values (inhibitory dose inhibited cell growth by 50%). A significant time-dependent 
inhibition of cell proliferation was not obtained when only exposing the cells to the lower 
concentrations after 72 h, and this did not strengthen along with the longer time of exposure. Low 
concentrations can kill cells immediately after treatment, but after longer time of exposure, cells 
recover and they can stimulate some proliferative effects in surviving cells. This correlates with the 
previously obtained results with HCT-116 cell line [15].  
Table 1 presents in vitro cytotoxic activities of the methanolic extracts of L. vulgare, which were 
expressed by IC50 values. The IC50 value was used as a parameter for cytotoxicity. The results showed 
that maximum effect has methanolic leaf extract after 24 h (28.2 μg/mL), indicating this time as the 
most effective time exposure for antiproliferative effects.  
Table 1. Growth inhibitory effects—IC50 values (μg/mL) of methanolic leaf and fruit 
extracts of L. vulgare on HCT-116 cell line after 3, 6, 12, 24 and 72 h of treatment.  
Methanolic extracts 
of L. vulgare 
After 3 h  After 6 h  After 12 h  After 24 h  After 72 h 
leaf  > 500  159.5 ± 1.92  147.8 ± 7.29  28.2 ± 0.76  64.6 ± 3.84 
fruit  > 500  325.9 ± 4.51  240.8 ± 3.64  47.4 ± 3.54  108.0 ± 5.32 Int. J. Mol. Sci. 2012, 13                 
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Figure 1. Effects of methanolic leaf extract (1) and fruit extract (2) of L.vulgare  on  
HCT-116 cell proliferation. The cells were treated with various concentrations of extracts 
and antiproliferative activities were measured by MTT assay after 3, 6, 12, 24 and 72 h of 
treatment. Results were expressed as means ± SE for three independent determinations. 
 
Natural bioactive substances can modify redox status and interfere with basic cellular functions 
(cell cycle, apoptosis, inflammation, angiogenesis, invasion and metastasis) [16]. Apoptosis is 
important in embryological development, cell proliferation, cell differentiation, elimination of 
seriously damaged cells or tumor cells by chemopreventive or chemotherapeutic agents and many 
other physiological processes [17]. Apoptotic cells and bodies are rapidly recognized by macrophages 
before cell lysis, and then can be removed without inducing inflammation. Therefore, the induction of 
apoptosis is an important mechanism of chemoprevention and chemotherapy of cancer. To determine 
whether the inhibition of cell proliferation by methanolic extracts from L. vulgare was due to the 
induction of apoptosis, we assessed the latter with the acridine orange/ethidium bromide method. 
Proapoptotic activity of methanolic extracts from L. vulgare was investigated with respect to the 
morphological shape of cells by fluorescence microscopy. Fluorescence microscopy images clearly 
showed morphological changes such as reduction in size and cell volume, cell shrinkage, membrane 
blebbing, chromatin condensation, nuclear fragmentation and formation of apoptotic bodies of treated 
cells (Figure 2).  
Table 2 summarizes the results obtained with AO/EB double staining. The percentages of viable, 
apoptotic and necrotic cells were noted for different incubation periods with extracts (Table 1). Typical 
morphological changes after different time periods are shown on Figure 2. A time dependent increase 
in induction of apoptosis was also observed, except for 72 h treatment, which was also apparent in the 
results from the MTT assay. Compared with spontaneous apoptosis observed in control cells, HCT-116 
treated with 100 µg/mL methanolic extracts of L. vulgare showed increased percentages of early 
apoptotic cells (the higest increase showed methanolic leaf extract of L. vulgare: 45.7%, after 24 h), 
and increased percentages of necrotic cells (the highest increase showed methanolic fruit extract of  
L. vulgare: 3.1%, after 72 h). Int. J. Mol. Sci. 2012, 13                 
 
 
2525
Figure 2. Typical morphological changes of HCT-116 cells induced by 100 µg/mL 
methanolic extracts of L. vulgare, stained with AO/EB. The images were taken using 
fluorescence microscopy at 400×. C: control, no treated cells; MB: membrane blebbing; 
CC: chromatin condensation; EA: early apoptosis; LA: late apoptosis; AB: apoptotic body; 
N: necrosis.  
 
Table 2. Different values of viable, apoptotic and necrotic cells as percentage of all cells, 
measured by AO/EB fluorescence staining, after treatment by 100 µg/mL of methanolic 
extracts of L. vulgare. The percentages of cells were measured after 3, 6, 12, 24 and 72 h  
of treatment. VC-viable cells; EA-early apoptosis; LA-late apoptosis; N-necrosis.  
 VC  EA  LA  N 
3 h 
untreated cells  96.5 ± 0.19  3.4 ± 0.26  0.1 ± 0.13   
leaf extract  83.3 ± 1.37  16.4 ± 1.34  0.2 ± 0.09  0.1 ± 0.08 
fruit extract  80.0 ± 4.14  16.1 ± 4.48  3.1 ± 0.23  0.7 ± 0.1 
6 h 
untreated cells  87.3 ± 7.09  12.7 ± 0.28  0.1 ± 0.105  − 
leaf extract  74.4 ± 3.53  25.2 ± 3.59  0.4 ± 0.027  − 
fruit extract  77.0 ± 6.11  22.9 ± 6.10  −  − 
12 h 
untreated cells  90.9 ± 0.08  8.7 ± 0.215  0.4 ± 0.29  − 
leaf extract  56.1 ± 2.08  41.3 ± 2.48  2.5 ± 1.57  0.1 ± 0.07 
fruit extract  73.6 ± 4.78  25.9 ± 4.71  0.2 ± 0.17  0.1 ± 0.06 
24 h 
untreated cells  96.3 ± 0.38  2.2 ± 0.10  1.4 ± 0.29  − 
leaf extract  52.5 ± 2.10  45.7 ± 2.47  1.9 ± 0.36  − 
fruit extract  53.2 ± 3.85  45.6 ± 4.52  1.2 ±0.66  − 
72 h 
untreated cells  97.1 ± 3.58  2.9 ± 2.15  −  − 
leaf extract  68.3 ± 2.59  29.4 ± 1.87  2.3 ± 0.35  − 
fruit extract  71.9 ± 1.13  21.8 ± 0.98  1.2 ± 1.01  3.1 ± 0.15 Int. J. Mol. Sci. 2012, 13                 
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The AO/EB and the MTT assays showed similar time-dependent effects on viability but the percent 
of viabilities were different. In MTT assays absorbance of control cells were considered as 100% and 
percentages of viable cells were calculated as ratio to the control, while in AO/EB assay percentages of 
viable cells are real numbers, calculated as ratio to the total number of cells in treatment. If there is a 
difference in viability it is because mitochondrial function assays (MTT) detected cell death earlier 
than others, while apoptosis indicating assays (AO/EB) detected cell death later in the process, which 
is in correlation with other data [18].  
According to obtained results we can conclude that L. vulgare has antiproliferative properties which 
increase with exposure time up to 24 h, when extracts have the best activity. The methanolic   
leaf extract has better antiproliferative activity than the methanolic fruit extract with lower IC50 values,  
and induces a higher percentage of apoptotic cells after 12 h of exposure. Extracts were able to induce 
cell apoptosis, but they did not induce necrosis in HCT-116 cells. Necrotic cells appeared in a very  
small percentage.  
The mechanism of action is unclear and, possibly, multiple compounds in the herbal extracts are 
involved [19]. Plant-derived chemical constituents, flavonoids, iridoids, coumarins, phenyl propanes 
and essential oil were reported to be the main constituents in L. vulgare but which are responsible for 
biological activities is not known [20].  
2.2. Antiproliferative Effects of L. vulgare Extracts in co-Treatment with Pd(apox) Complex  
Cancer is the third leading cause of death worldwide, preceded by cardiovascular and infectious 
diseases. There are standard chemotherapeutic drugs for treatment of cancers. Several studies have 
shown that chemotherapeutic drugs have harmful effects on health and can lead to the development of 
drug resistance in tumor cells, which limit the clinical success of cancer chemotherapy [21,22]. Recent 
reports show that chemotherapeutic drugs and natural compounds with known anti-cancer activity 
could be used in combination therapy to reduce the systemic toxicity of chemotherapeutic   
agents [23,24]. So-called natural compounds with anti-cancer activity often modify many intracellular 
signaling pathways simultaneously. Previous reports demonstrated that many side effects of common 
used chemotherapy agents are consequences of induction of oxidative stress, which could be palliated 
by antioxidant food and plants [25].  
In this study, the antiproliferative and proapoptotic activity of the methanolic extracts of L. vulgare 
and the chemotherapeutic drug—Pd(apox) complex were investigated in HCT-116 cells by MTT cell 
viability assay and AO/EB assay. Different combinations of Pd(apox) and plant extracts were used  
to find those combinations showing the highest potential to reduce viability of HCT-116 cells. 
Combination assays were performed using appropriate concentrations of methanolic extracts of   
L. vulgare (1, 50, 100 and 250 μg/mL) with appropriate concentrations of Pd(apox) complex (100 and 
250 μM). The Pd(apox) complex was added after 3, 6 and 24 h of cell incubation with plant extract. 
Cell viability was measured after 24 h (for cells where Pd(apox) was added after 3 and 6 h of cell 
exposure to plant extracts) and after 72 h (for cells where Pd(apox) was added after 24 h of cell 
exposure to plant extracts). Cells treated with the same final concentrations of the extracts or 
chemotherapeutic drugs alone were also examined.  Int. J. Mol. Sci. 2012, 13                 
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The MTT assay indicated that the Pd(apox) complex had very weak antiproliferative activity 
(96.7% and 94.3% of viability cells in treatment with 100 μM and 250 μM Pd(apox) for 24 h; 96.1% 
and 91.3% of viability cells in treatment with 100 μM and 250 μM Pd(apox) for 72 h). Literature data 
also imply that palladium compounds are not stable and therefore in the cellular environment will be 
translabilized easily by other biomolecules such as GSH, giving intermediates [26].  
L. vulgare extracts were selectively toxic against HCT-116 cell line over different time periods, and 
in combination with Pd(apox) complex produced an increased growth inhibitory effect (Figures 3 and 
4) with lower IC50 values (Table 3). The addition of Pd(apox) complex significantly reduces the IC50 
values (calculated in relation to the concentration of plant extract), although Pd (in individual treatment) 
did not show antiproliferative activity. The best antiproliferative activity was observed with   
the combination of leaf extract and 250 μM Pd(apox) complex measured after 72 h (IC50 = 4.8 ± 0.6). 
The results indicate that Pd(apox) complex and plant extracts have synergistic effects on cell 
proliferation inhibition. 
Figure 3. Antiproliferative activity of methanolic leaf extract of L. vulgare alone and in 
combinations with Pd(apox) complex on HCT-116 cell line. Cells were treated with plant 
extracts and after 3, 6 and 24 h of incubation Pd(apox) complex was added. The 
antiproliferative activity was measured by MTT assay after 24 h (1 and 2) and 72 h (3) of 
initial treatment with plant extracts. Results were expressed as means ± SE for three 
independent determinations.  
 Int. J. Mol. Sci. 2012, 13                 
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Figure 4. Antiproliferative activity of methanolic fruit extract of L. vulgare alone and in 
combinations with Pd(apox) complex on HCT-116 cell line. Cells were treated with plant 
extracts and after 3, 6 and 24 h of incubation Pd(apox) complex was added. The 
antiproliferative activity was measured by MTT assay after 24 h (1 and 2) and 72 h (3) of 
initial treatment with plant extracts. Results were expressed as means ± SE for three 
independent determinations.  
 
Table 3. Growth inhibitory effects—IC50 values (μg/mL) of methanolic leaf and fruit 
extracts of L. vulgare in combination with Pd(apox) complex on HCT-116 cell line. IC50 
values was calculated in relation to the concentration of plant extract. Cells were treated 
with plant extracts and after 3, 6 and 24 h of incubation Pd(apox) complex was added. The 
antiproliferative activities were measured by MTT assay after 24 and 72 h of initial 
treatment with plant extracts. Results were expressed as means ± SE for three independent 
determinations.  
combination of 
drugs 
Measured after 24 h  Measured after 72 h 
Pd(apox) complex added 
after 3 h of cell 
incubation with plant 
extract 
Pd(apox) complex 
added after 6 h of cell 
incubation with plant 
extract 
Pd(apox) complex added 
after 24 h of cell 
incubation with plant 
extract 
Leaf extract and  
100 μM Pd 
269.5 ± 2.89  13.8 ± 1.21  27.1 ± 1.47 
Leaf extract and  
250 μM Pd 
121.1 ± 3.25  5.5 ± 0.75  4.8 ± 0.65 
Fruit extract and  
100 μM Pd 
347.9 ± 4.63  33.5 ± 1.56  145.4 ± 1.26 
Fruit extract and  
250 μM Pd 
422.2 ± 5.41  8.1 ± 1.01  6.0 ± 0.25 Int. J. Mol. Sci. 2012, 13                 
 
 
2529
Similar viability results for Pd(apox) complex were obtained from the AO/EB assay (96.9% and 
94.9% of viability cells in treatment with 100 μM and 250 μM Pd(apox) for 24 h; 96.7% and 92.7% of 
viability cells in treatment with 100 μM and 250 μM Pd(apox) for 72 h). Table 4 summarizes the 
percentages of viable, apoptotic and necrotic cells observed by addition of the Pd(apox) complex in 
combination with plant extracts over different time periods. A time-dependent increase in induction of 
apoptosis was also observed. The HCT-116 treated with different drug combinations showed an 
increase in the percentage of early apoptotic cells (combination of methanolic leaf extract of L. vulgare 
and 250 μM Pd(apox) complex: 45.2%, after 6 h showed the higest increase of early apoptotic cells), 
and increased the percentage of late apoptotic cells (the highest increase showed with the combination 
of methanolic leaf extract of L. vulgare and 250 μM Pd(apox) complex, after 72 h).  
Table 4. Different values of viable, apoptotic and necrotic cells as percentage of all cells 
measured by AO/EB fluorescence staining. Cells were treated with 100 µg/mL plant 
extracts and after 3, 6 and 24 h of incubation Pd(apox) complex was added. The cell 
percentages were measured after 24 and 72 h of initial treatment with plant extracts. 
Results were expressed as means ± SE for three independent determinations. VC-viable 
cells; EA-early apoptosis; LA-late apoptosis; N-necrosis. 
Time of cell counting    VC  EA  LA  N 
after 24 h  control, untreated   96.3 ± 0.38 2.2 ± 0.10  1.4 ± 0.29  - 
after 72 h  cells  97.1 ± 3.58 2.9 ± 2.15  -  - 
24 h after treatment 
100 μM Pd(apox) 
complex  98.1 ± 0.89 1.9 ± 0.28  -  - 
250 μM Pd(apox) 
complex  96.6 ± 3.81 3.4 ± 1.09  -  - 
Pd(apox) complex  combination of drugs        
24 h after 
initial 
treatment 
with plant 
extracts 
after 3 h 
leaf extract and  
100 μM Pd  74.1 ± 0.93 25.7 ± 0.47 0.2 ± 0.29  - 
leaf extract and  
250 μM Pd  62.3 ± 6.35 36.5 ± 4.39 1.1 ± 0.39  - 
fruit extract and  
100 μM Pd  79.1 ± 0.77 20.7 ± 1.24 0.2 ± 0.74  - 
fruit extract and  
250 μM Pd  68.9 ± 4.05 31.1 ± 1.87 -  - 
after 6 h 
leaf extract and  
100 μM Pd  44.9 ± 4.76 41.1 ± 0.79 13.7 ± 1.25  0.2 ± 2.56
leaf extract and  
250 μM Pd  32.1 ± 2.68 45.2 ± 5.05 20.8 ± 1.74  1.8 ± 3.21
fruit extract and  
100 μM Pd  59.1 ± 1.57 32.7 ± 0.41 8.2 ± 1.13  - 
fruit extract and 250 
μM Pd  50.1 ± 2.91 39.7 ± 2.31 10.1 ± 2.01  - 
72 h after 
initial 
treatment 
with plant 
extracts 
after 24 h 
leaf extract and  
100 μM Pd  37.1 ± 1.58 26.7 ± 1.87 34.3 ± 1.36  1.8 ± 0.97
leaf extract and 
 250 μM Pd  30.5 ± 2.02 29.5 ± 2.14 37.9 ± 1.91  2.1 ± 1.67
fruit extract and  
100 μM Pd  40.8 ± 2.14 30.6 ± 1.57 25.9 ± 1.36  2.6 ± 1.07
fruit extract and  
250 μM Pd  42.9 ± 1.64 31.3 ± 1.42 24.8 ± 1.42  1.0 ± 1.34Int. J. Mol. Sci. 2012, 13                 
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It might be possible that L. vulgare extracts could induce reactive oxygen species (ROS) in the 
induction of apoptosis. The ROS production were confirmed for some components from L. vulgare 
such as flavonoids, terpenoids and other components [27,28]. These findings suggest that L. vulgare 
extracts could induce apoptosis in HCT-116 cells may be by a ROS mediated mechanism and inhibit 
the glutathione conjugate export pump. Also the extracts could increase the sensitivity of HCT-116 
cells to Pd(apox) complex. As a result, the sensitivity of tumor cells to anticancer drugs was   
increased [29,30]. The explanation of all the aspects and mechanism of the synergistic effects of   
L. vulgare extracts and Pd(apox) complex will be the next step in our investigation of this problem.  
3. Experimental Section 
3.1. Chemicals  
Methanol was purchased from “Zorka pharma”, Serbia. Dublecco’s Modified Eagle Medium (DMEM) 
was obtained from GIBCO, Invitrogen, USA. Fetal bovine serum (FBS) and trypsin-EDTA were from 
PAA (The cell culture company), Austria. Acridine orange was obtained from Acros organic, New 
Jersey, USA. Dimethyl sulfoxide (DMSO), ethidium bromide and 3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyltetrazolium bromide (MTT) were obtained from SERVA, Germany. The ligand N,N'-bis(3-
aminopropy1)oxamide(H2apox) was synthesized by following the procedures described in the 
literature. Potassium tetrachloro-paladate(II) was purchased from Aldrich and used as supplied. 
Reagent grade, commercially available, chemicals were used without further purification.  
3.2. Preparation of [Pd(apox)] 
Of the ligand H2apox(N,N′-bis(3-aminopropyl)oxamide) [31] 0.303 g was dissolved in 5 cm
3 of 
water and then 0.163 g of K2PdCI4 was added slowly to the stirred solution. The pH of solution in the 
course of the addition of K2PdCI4 was kept approximately neutral by addition of KOH solution. The 
resulting solution was filtered and then allowed to stand at room temperature. Yellow crystals were 
obtained. Analytical calculation for C8H16N4O2Pd: C, 31.33; H, 5.26; N, 18.27. Found: C, 31.02; H, 
5.33; N, 17.98.  
3.3. Preparation of Plant Extracts 
Prepared plant material (10 g) was transferred to dark-coloured flasks. It was soaked in 200 mL of 
methanol and stored at room temperature. After 24 h, the infusions were filtered through Whatman  
No. 1 filter paper and the residue was re-extracted with equal volume of solvents. After 48 h, the 
process was repeated. Combined supernatants were evaporated to dryness under vacuum at 40 °C 
using a Rotary evaporator. The obtained extracts were kept in sterile sample tubes and stored in a 
refrigerator at 4 °C. 
3.4. Cell Preparation, Culturing and Treatments 
HCT-116 cell line was obtained from American Type Culture Collection. Cells were maintained in 
DMEM supplemented with 10% Fetal Bovine Serum, with 100 units/mL penicillin and 100 µg/mL Int. J. Mol. Sci. 2012, 13                 
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streptomycin. Cells were cultured in a humidified atmosphere with 5% CO2 at 37 °C. Cells were 
grown in 75 cm
2 culture bottles supplied with 15 mL DMEM, and after a few passages, cells were 
seeded in a 96-well plate. The experiments were done at 70 to 80% confluence.  
HCT-116 cells were seeded in a 96-well plate (10,000 cells/well). After 24 h of cells incubation, the 
medium was replaced with 100 μL medium containing methanolic leaf and fruit extracts of L. vulgare 
at different concentrations (1, 10, 50, 100, 250 and 500 μg/mL). Untreated cells served as controls.  
For determination of time dependence, cell viability was determined by MTT assay and type of cell 
death was determined by AO/EB assay under a fluorescent microscope after appropriate incubation 
times with plant extracts (3, 6, 12, 24 and 72 h).  
For investigation of combination effects of plant extracts and Pd(apox) complex on cell 
proliferation, 10,000 cells/well were seeded in 96-well plates. After 24 h the cells were exposed to four 
concentrations of methanolic leaf and fruit extracts of L. vulgare (1, 50, 100 and 250 μg/mL). Pd(apox) 
complex (100 and 250 μM) was added after 3, 6 and 24 h of cell incubation with plant extracts. 
Absorbance was measured and cells were counted after 24 h (for cells where Pd(apox) was added after 
3 and 6 h of cell exposure to plant extracts) and 72 h (for cells where Pd(apox) was added after  
24 h of cell exposure to plant extracts) from initial treatments with plants. AO/EB assay for analysis of 
cell death was also used over the same time intervals and the same combinations of concentrations. 
Cells were also treated with Pd(apox) complex (100 and 250 μM) alone. 
3.5. Cell Viability Assay (MTT Assay)  
The cell viability was determined by MTT assay [32]. The proliferation test is based on the color 
reaction of mitochondrial dehydrogenase in living cells by MTT. At the end of the treatment period, 
MTT (final concentration 5 mg/mL PBS) was added to each well, which was then incubated at 37 °C 
in 5% CO2 for 2–4 h. The colored crystals of produced formazan were dissolved in 150 μL DMSO. 
The absorbance was measured at 570 nm on a Microplate Reader. Cell proliferation was calculated as 
the ratio of absorbance of the treated group divided by the absorbance of the control group, multiplied 
by 100 to give a percentage proliferation. 
3.6. Fluorescence Microscopic Analysis of Cell Death 
We used acridine orange/ethidium bromide (AO/EB) double staining assay [33]. Acridine orange is 
taken up by both viable and nonviable cells and emits green fluorescence if interrelated into double 
stranded nucleic acid (DNA) or red fluorescence if bound to single stranded nucleic acid (RNA). 
Ethidium bromide is taken up only by nonviable cells and emits red fluorescence by intercalation into 
DNA. We distinguished four types of cells according to the fluorescence emission and the 
morphological aspect of chromatin condensation in the stained nuclei. Viable cells have uniform bright 
green nuclei with an organized structure. Early apoptotic cells (which still have intact membranes but 
have started to undergo DNA cleavage) have green nuclei, but perinuclear chromatin condensation is 
visible as bright green patches or fragments. Late apoptotic cells have orange to red nuclei with 
condensed or fragmented chromatin. Necrotic cells have uniformly orange to red nuclei with a 
condensed structure. The amount of 20 µL of dye mixture (10 µL/mg AO and 10 µL/mg EB in 
distilled water) was mixed with 100 µL cell suspension (10,000 cells/mL) in a 96-well plate. After the Int. J. Mol. Sci. 2012, 13                 
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incubation times with the drugs the suspension was immediately examined and viewed under a Nikon 
inverted fluorescent microscope (Ti-Eclipse) at 400× magnification. We observed untreated cells as 
controls. A minimum of 300 cells was counted in each sample. Results were expressed as means ± SE 
for three independent determinations.  
3.7. Statistical Analysis 
The data are expressed as means ± standard errors (SE). Biological activity was examined in three 
individual experiments, performed in triplicate for each dose. Statistical significance was determined 
using the Student’s t-test or the one-way ANOVA test for multiple comparisons. A p value <0.05 was 
considered as significant. The magnitude of correlation between variables was done using a SPSS 
(Chicago, IL) statistical software package (SPSS for Windows, ver. 17, 2008). The IC50 values were 
calculated from the dose curves by a computer program (CalcuSyn).  
4. Conclusions  
The study concludes that L. vulgare might be considered as a potential source of metabolites which 
could be developed as precursors for anti-cancer drugs. There is/are active constituent(s) in L. vulgare 
with anti-proliferative effect against HCT-116 cells. It is nessesary in the future to determine the   
type of constituents with potential activities. Isolation, purification and consideration of possible 
applications of these active compounds are in prospect.  
To summarize, our results demonstrate that methanolic leaf and fruit extracts of L. vulgare had the 
best antiproliferative and proapototic effects after 24 h with prolonged exposure being less effective. 
The extracts from leaves had higher antiproliferative activity (with lower IC50 values) than fruit 
extracts. Combinations of methanolic extracts of L.vulgare with Pd(apox) complex in HCT-116 cell 
lines had better antiproliferative effects than either agent alone, with significantly lower IC50 values. 
Leaf extracts had better synergistic effects with the Pd(apox) complex than fruit extracts. Further 
studies are needed to assess the underlying mechanisms (e.g., signal transduction pathways) leading to 
growth inhibition induced by single agents and combinations both in vitro and in vivo. A positive 
outcome of such studies would increase the efficacy of existing chemotherapies with reduced toxicity 
to normal tissues in the treatment of human colon cancer.  
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